175 related articles for article (PubMed ID: 22410201)
21. Combined immunosuppressive therapy including a TNF-alpha blocker induces remission in a difficult to treat patient with Takayasu arteriitis and coronary involvement.
Mahlmann A; Pfluecke C; Ouda A; Simonis G; Weiss N; Kappert U
Vasa; 2012 Nov; 41(6):451-7. PubMed ID: 23129041
[TBL] [Abstract][Full Text] [Related]
22. Takayasu's arteritis progression on anti-TNF biologics: a case series.
Osman M; Aaron S; Noga M; Yacyshyn E
Clin Rheumatol; 2011 May; 30(5):703-6. PubMed ID: 21221688
[TBL] [Abstract][Full Text] [Related]
23. Takayasu's arteritis: reversal of pulse deficit after early treatment with corticosteroids.
Gardner JD; Lee KR; Abdou NI
J Rheumatol; 1984 Feb; 11(1):92-3. PubMed ID: 6142115
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide.
Kong X; Zhang X; Lv P; Cui X; Ma L; Chen H; Liu H; Lin J; Jiang L
Int J Cardiol; 2018 Sep; 266():222-228. PubMed ID: 29729868
[TBL] [Abstract][Full Text] [Related]
25. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
26. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E
J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of leflunomide in glucocorticoid- and methotrexate-resistant Takayasu's arteritis.
Haberhauer G; Kittl EM; Dunky A; Feyertag J; Bauer K
Clin Exp Rheumatol; 2001; 19(4):477-8. PubMed ID: 11491512
[No Abstract] [Full Text] [Related]
28. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.
Park MC; Lee SW; Park YB; Chung NS; Lee SK
Scand J Rheumatol; 2005; 34(4):284-92. PubMed ID: 16195161
[TBL] [Abstract][Full Text] [Related]
29. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
[TBL] [Abstract][Full Text] [Related]
30. [Takayasu's arteritis--case report and review of the literature].
Schurch MA; Gerster JC
Rev Med Suisse Romande; 2000 Oct; 120(10):777-80. PubMed ID: 11109906
[TBL] [Abstract][Full Text] [Related]
31. Successful golimumab therapy in four patients with refractory Takayasu's arteritis.
Suematsu R; Tashiro S; Ono N; Koarada S; Ohta A; Tada Y
Mod Rheumatol; 2018 Jul; 28(4):712-715. PubMed ID: 26707139
[TBL] [Abstract][Full Text] [Related]
32. Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis.
Kaymaz-Tahra S; Bayindir O; Ince B; Ozdemir İsik O; Kutu ME; Karakas O; Yildirim TD; Ademoglu Z; Ediboglu ED; Uludogan BCE; Ilgin C; Bilge NSY; Kasifoglu T; Akar S; Emmungil H; Onen F; Omma A; Kanitez NA; Yazici A; Cefle A; Inanc M; Aksu K; Keser G; Direskeneli H; Alibaz-Oner F
Semin Arthritis Rheum; 2024 Jun; 66():152446. PubMed ID: 38669786
[TBL] [Abstract][Full Text] [Related]
33. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
Villiger PM
Internist (Berl); 2019 Oct; 60(10):1059-1073. PubMed ID: 31471629
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis.
Oguro E; Ohshima S; Kikuchi-Taura A; Murata A; Kuzuya K; Okita Y; Matsuoka H; Teshigawara S; Yoshimura M; Yoshida Y; Isoda K; Kudo-Tanaka E; Harada Y; Kaminou T; Saeki Y
Intern Med; 2019 May; 58(9):1355-1360. PubMed ID: 30626815
[TBL] [Abstract][Full Text] [Related]
35. Biotherapies in large vessel vasculitis.
Ferfar Y; Mirault T; Desbois AC; Comarmond C; Messas E; Savey L; Domont F; Cacoub P; Saadoun D
Autoimmun Rev; 2016 Jun; 15(6):544-51. PubMed ID: 26883459
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the management of Takayasu arteritis.
Misra DP; Wakhlu A; Agarwal V; Danda D
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():60-68. PubMed ID: 30698358
[TBL] [Abstract][Full Text] [Related]
37. [Clinical symptoms variety as a cause of late diagnosed Takayasu's arteritis].
Czuszyńska Z; Debski J; Szurowska E; Hebanowski M; Łuszczyńska-Nitka G
Pol Merkur Lekarski; 2002 Dec; 13(78):503-5. PubMed ID: 12666452
[TBL] [Abstract][Full Text] [Related]
38. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
[TBL] [Abstract][Full Text] [Related]
39. Takayasu's arteritis associated with antiphospholipid antibodies.
Morović-Vergles J
Rheumatol Int; 2006 Jun; 26(8):773-4. PubMed ID: 16231120
[No Abstract] [Full Text] [Related]
40. [Association of sarcoidosis and Takayasu's arteritis: an additional case report].
Robaday S; Hervé F; Cailleux N; Dominique S; Levesque H; Marie I
Rev Med Interne; 2005 Oct; 26(10):816-9. PubMed ID: 16023270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
